Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
|
Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
|
6B CNY |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.5B USD |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
9.1T JPY |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
30.1B CHF |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
120.8B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.7B USD |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.7B GBP |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.9B CNY |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.9B USD |
Loading...
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4B CHF |
Loading...
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
7.2T KRW |
Loading...
|
Market Distribution
| Min | -409 046.1% |
| 30th Percentile | -1.4% |
| Median | 4.2% |
| 70th Percentile | 10.3% |
| Max | 876.4% |
Other Profitability Ratios
Jiangsu Bioperfectus Technologies Co Ltd
Glance View
Jiangsu Bioperfectus Technologies Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents and supporting testing instruments. The company is headquartered in Taizhou, Jiangsu and currently employs 765 full-time employees. The company went IPO on 2019-12-05. The firm's products mainly include in vitro diagnostic reagents, supporting testing instruments and in vitro testing services. Its products are mainly used in the fields of infectious disease prevention and control, clinical testing, large-scale population screening, as well as prenatal and postnatal care management. The firm mainly conducts its businesses in domestic and overseas markets.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Jiangsu Bioperfectus Technologies Co Ltd is -22.6%, which is above its 3-year median of -29.7%.
Over the last 3 years, Jiangsu Bioperfectus Technologies Co Ltd’s Operating Margin has decreased from 41.6% to -22.6%. During this period, it reached a low of -91.8% on Mar 31, 2024 and a high of 41.6% on Aug 30, 2022.
